Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mar Drugs ; 17(2)2019 Feb 01.
Article in English | MEDLINE | ID: mdl-30717235

ABSTRACT

The marine α-pyrone macrolide neurymenolide A was previously isolated from the Fijian red macroalga, Neurymenia fraxinifolia, and characterized as an antibacterial agent against antibiotic-resistant strains that also exhibited moderate cytotoxicity in vitro against cancer cell lines. This compound was also shown to exhibit allelopathic effects on Scleractinian corals. However, to date no mechanism of action has been described in the literature. The present study showed, for the first time, the isolation of neurymenolide A from the New Caledonian Rhodophyta, Phacelocarpus neurymenioides. We confirmed the compound's moderate cytotoxicity in vitro against several human cell lines, including solid and hematological malignancies. Furthermore, we combined fluorescence microscopy and flow cytometry to demonstrate that treatment of U-2 OS osteosarcoma human cells with neurymenolide A could block cell division in prometaphase by inhibiting the correct formation of the mitotic spindle, which induced a mitotic catastrophe that led to necrosis and apoptosis. Absolute configuration of the stereogenic center C-17 of neurymenolide A was deduced by comparison of the experimental and theoretical circular dichroism spectra. Since the total synthesis of this compound has already been described, our findings open new avenues in cancer treatment for this class of marine molecules, including a new source for the natural product.


Subject(s)
Macrolides/chemistry , Macrolides/pharmacology , Pyrones/chemistry , Pyrones/pharmacology , Rhodophyta/chemistry , Spindle Apparatus/drug effects , Apoptosis/drug effects , Bone Neoplasms/drug therapy , Bone Neoplasms/pathology , Cell Line, Tumor , Drug Screening Assays, Antitumor , Hep G2 Cells , Humans , K562 Cells , MCF-7 Cells , Microtubules/pathology , Mitosis/drug effects , Necrosis/drug therapy , Osteosarcoma/drug therapy , Osteosarcoma/pathology
2.
Mar Drugs ; 14(3)2016 Mar 16.
Article in English | MEDLINE | ID: mdl-26999165

ABSTRACT

Marine micro- and macroorganisms are well known to produce metabolites with high biotechnological potential. Nearly 40 years of systematic prospecting all around the New Caledonia archipelago and several successive research programs have uncovered new chemical leads from benthic and planktonic organisms. After species identification, biological and/or pharmaceutical analyses are performed on marine organisms to assess their bioactivities. A total of 3582 genera, 1107 families and 9372 species have been surveyed and more than 350 novel molecular structures have been identified. Along with their bioactivities that hold promise for therapeutic applications, most of these molecules are also potentially useful for cosmetics and food biotechnology. This review highlights the tremendous marine diversity in New Caledonia, and offers an outline of the vast possibilities for natural products, especially in the interest of pursuing collaborative fundamental research programs and developing local biotechnology programs.


Subject(s)
Aquatic Organisms/metabolism , Biodiversity , Biological Products/pharmacology , Animals , Biological Products/chemistry , Biological Products/isolation & purification , Biotechnology/methods , Cosmetics/chemistry , Humans , New Caledonia
SELECTION OF CITATIONS
SEARCH DETAIL